NGS-based profiling of key cancer genes in Indian triple-negative breast cancer patients reinforces molecular heterogeneity of the disease

dc.contributor.authorSahasrabuddhe, Nandini A.en_US
dc.contributor.authorKorlimarla, Arunaen_US
dc.contributor.authorKULKARNI, MADHURAen_US
dc.contributor.authorKusuma, Vinayen_US
dc.contributor.authorPrabhu, Jyothi S.en_US
dc.contributor.authorDIXIT, SANTOSHen_US
dc.contributor.authorDeshmukh, Chetanen_US
dc.contributor.authorSridhar, T.S.en_US
dc.contributor.authorPhatak, Adityaen_US
dc.contributor.authorKOPPIKER, CHAITANYANANDAen_US
dc.contributor.departmentDept. of Biologyen_US
dc.date.accessioned2022-04-04T08:56:46Z
dc.date.available2022-04-04T08:56:46Z
dc.date.issued2021-09en_US
dc.description.abstractTriple-negative breast cancers (TNBC) are one of the most aggressive forms of breast cancers. With poor patient outcomes, it presents a great burden on the healthcare systems. There have been some efforts to explore the genomic changes that occur in TNBCs. However, there is not enough data on Indian TNBCs. We sought to understand the mutational landscape of key cancer-associated genes in Indian TNBC patients using TruSeq Cancer Amplicon Panel. We sequenced 51 TNBC patient samples and found great heterogeneity amongst samples with respect to the genomic variants. Several previously reported including alterations in PI3K-AKT pathway genes were also identified. Likewise, we identified several novel high-frequency variants, for example, GNAQ F341S (17%), the functional role of which remains unclear. Our study lays the foundation of larger efforts needed to understand the genomic landscape of Indian TNBCs which can aid in classification and better therapeutic management of patients.en_US
dc.identifier.citationIndian Journal of Cancer, 58 (4), 598-602.en_US
dc.identifier.issn0019-509Xen_US
dc.identifier.issn1998-4774en_US
dc.identifier.sourcetitleIndian Journal of Canceren_US
dc.identifier.urihttps://doi.org/10.4103/ijc.IJC_432_20
dc.identifier.urihttp://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/6721
dc.language.isoenen_US
dc.publication.originofpublisherIndianen_US
dc.publisherWolters Kluweren_US
dc.subjectMutationen_US
dc.subjectNext-generation sequencingen_US
dc.subjectPrecision medicineen_US
dc.subjectTriple-negative breast canceren_US
dc.subject2021en_US
dc.titleNGS-based profiling of key cancer genes in Indian triple-negative breast cancer patients reinforces molecular heterogeneity of the diseaseen_US
dc.typeArticleen_US

Files

Collections